Bioswitches: Towards programmable, on-demand control of therapeutic proteins

References

[1] Wolf B, Shehu P, Brenker L, et al. Rational engineering of allosteric protein switches by in silico prediction of domain insertion sites. Nat Methods. 2025; 22: 1698-1706.

[2] Hoffmann KH, Kroell AS, Motzkus NA, et al. Modular Engineering of Thermo-Responsive Allosteric Proteins. 2025; 2025.05.02.651844 Preprint at

[3] Brenker L, Aschenbrenner S, Bubeck F, et al. A versatile anti-CRISPR platform for opto- and chemogenetic control of CRISPR-Cas9 and Cas12 across a wide range of orthologs. Nucleic Acids Res. 2025; 53:gkaf752.

[4] Marchand A, Buckley S, Schneuing A, et al. Targeting protein–ligand neosurfaces with a generalizable deep learning tool. Nature. 2025; 639: 522-531.

[5] An L, Said M, Tran L, et al. Binding and sensing diverse small molecules using shape-complementary pseudocycles. Science. 2024; 385: 276-282.

[6] Lu L, Gou X, Tan SK, et al. De novo design of drug-binding proteins with predictable binding energy and specificity. Science. 2024; 384: 106-112.

[7] Guo Z, Smutok O, Ronacher C, et al. Lanthanide-controlled protein switches: development and in vitro and in vivo applications. Angew Chem Int Ed. 2025; 64:e202411584.

[8] Gligorovski V, Labagnara M, Rahi SJ, Light-directed evolution of dynamic, multi-state, and computational protein functionalities. 2025; 2024.02.28.582517 Preprint at

[9] Southern, NT, von Bachmann A, Hovsepyan A, et al. Phage-Assisted Evolution of Allosteric Protein Switches. 2025; 2025.06.12.659331 Preprint at

RIGHTS & PERMISSIONS

2026 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.